0 (baseline) | ≥1<1.5 months1) | p-value2) | ≥3 months | p-value2) | |
---|---|---|---|---|---|
CBCL Total problems | 34 (9–39) | 21 (8–29) | ** | 21 (2–22) | ** |
YSR Total problems | 20 (9–36) | 11 (5–41) | n.s. | 2 (0–22) | ** |
S-tTGAbA | 42 (10–310) | 5 (3–51) | ** | 3 (1–17) | ** |
Prolactin3) | 1100 (635–2850) | 256 (127–282) | n.s * | 244 (110–565) | ** |
L-tyrosine4) | 33 (26–44) | 39 (37–70) | n.s * | 40 (38–47) | ** |
CAA5) | 353 (316–441) | 401 (368–657) | n.s * | 395 (367–568) | ** |
L-tryptophan4) | 40 (32–51) | 52 (45–66) | n.s * | 46 (36–59) | n.s. |
Tryptophan/CAA6) | 11.3 (10.1–14.9) | 12.0 (10.1–14.1) | n.s. | 10.1 (9.5–12.5) | n.s. |
Free L-tryptophan 4) | 4.9 (4.5–11.8) | 8.4 (5.3–10.9) | n.s * | 10.6 (5.0–19.0) | n.s. * 7) |
Free tryptophan/CAA6) | 1.4 (1.0–3.5) | 1.9 (1.0–3.0) | n.s. | 2.6 (1.3–3.4) | n.s. |